dtg
Showing 1 - 15 of 15
Dolutegravir Use in Human Immunodeficiency Virus Positive
Recruiting
- HIV Infections
- DTG
-
Barcelona, SpainGSK Investigational Site
Jul 21, 2022
HIV Trial (Lipovirtide 10mg, Lipovirtide 40mg, Lipovirtide 60mg)
Not yet recruiting
- HIV
- Lipovirtide 10mg
- +3 more
- (no location specified)
Sep 23, 2023
HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)
Active, not recruiting
- HIV-1/HBV Co-Infection
- B/F/TAF
- +5 more
-
Fort Pierce, Florida
- +66 more
Sep 19, 2022
HIV Infection Trial in Worldwide (DTG)
Active, not recruiting
- HIV Infection
- DTG
-
Frankfurt, Germany
- +27 more
Apr 27, 2021
HIV Trial in Canada, United States (CAB LA, RPV LA, RPV)
Active, not recruiting
- HIV Infections
- CAB LA
- +3 more
-
Phoenix, Arizona
- +29 more
Jan 22, 2023
HIV Trial in Austin (GSK3640254, DTG)
HIV Trial in Worldwide (DTG, LPV/RTV, Two NRTIs)
Completed
- HIV Infections
- DTG
- +2 more
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
- +58 more
Feb 23, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Overland Park (DTG, RPV, DTG/RPV FDC)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- DTG
- +2 more
-
Overland Park, KansasGSK Investigational Site
Jul 11, 2019
Infection, Human Immunodeficiency Virus Trial in Austin (DTG, BCV, TVR)
Completed
- Infection, Human Immunodeficiency Virus
- DTG
- +2 more
-
Austin, TexasGSK Investigational Site
Mar 27, 2017
Infection, Human Immunodeficiency Virus Trial in Overland Park (DTG, DCV)
Completed
- Infection, Human Immunodeficiency Virus
- DTG
- DCV
-
Overland Park, KansasGSK Investigational Site
Jun 5, 2014
Infection, Human Immunodeficiency Virus Trial in Overland Park (DTG, CBZ)
Completed
- Infection, Human Immunodeficiency Virus
- DTG
- CBZ
-
Overland Park, KansasGSK Investigational Site
Jan 23, 2014